Ka taƙaita labarin:  Wata mai ciwon daji ta ba da labarin yadda wata babbar ciwon daji da ke ƙarƙashin ƙirjinta na hagu ta 'ɓace' bayan wani sabon magani na farko. Matar mai shekaru 49 ta nuna amsa mai ban mamaki ga sabon hadewar kwayoyi biyu, don magance cutar sankarar fata. Likitoci a Memorial Sloan-Kettering Cancer Center a New York sun yaba wa murmurewar da majiyarsu ta yi 'ɗaya daga cikin amsoshi mafi ban mamaki' da aka taɓa gani. Masana kimiyya a asibitin sun gudanar da gwaji, suna kula da marasa lafiya da aka gano suna da cutar melanoma mai ci gaba tare da sabon nau'in magani. Sun haɗu da wani maganin da aka saba amfani da shi, ipilimumab, tare da wani, nivolumab. Wani babban ciwon daji mai shekaru 49 da haihuwa a karkashin kirjinsa na hagu (tauraruwa a hagu) an 'halaka shi gaba daya' kuma 'ya narke' (dama) bayan da ta karbi sabon magungunan magunguna don magance cutar melanoma. Suna fatan sabon maganin zai ceci dubban rayuka a nan gaba. Wani rahoto, wanda aka buga a cikin New England Journal of Medicine, ya bayyana cewa bayan da aka sha kashi ɗaya kawai na magungunan biyu, matar mai shekara 49 ta ba da rahoton ciwon tumo 'wani irin narkewa'. Shekaru huɗu da suka wuce likitoci sun cire wani melanoma na 4.2mm daga bayanta. Bayan magani, kuma bayan shekara daya da rabi, likitoci sun gano cewa ciwon kansa ya dawo. Sai kuma wata biyar da suka wuce, an cire wani ciwon daga ƙarƙashin nono na hagu na mai haƙuri. Amma duk da cewa an yi mini fiɗa, ciwon ya sake dawowa. Lokacin da mara lafiyar ta isa Memorial Sloan-Kettering Cancer Center, ta sami wata babbar ƙwayar cuta a ƙarƙashin ƙirjinta na hagu, wadda ta fito ta cikin fata. An bai wa matar kashi na farko na ipilimumab da nivolumab, ba tare da yin gunaguni game da wani sakamako masu illa ba. Lokacin da ta koma asibiti makonni uku bayan haka, don ta sha kashi na biyu na magungunan, ta bayyana wa likitoci cewa ƙwanƙolin da ke ƙarƙashin ƙirjinta na hagu ya 'bace,' ya bar rami a cikin fata. Likitocin da ke kula da ita sun ce: 'Wannan majiyar ta yi saurin kawar da babban ƙwayar ciwon bayan magani guda da aka yi mata da maganin rigakafi.' Yanzu, ba ta da wani melanoma da za a iya ganowa. 'Wannan shi ne daya daga cikin mafi...
Likitoci a Cibiyar Kula da Ciwon daji ta Memorial Sloan Kettering da ke New York suna gwaji da wani sabon hadadden magunguna don magance ciwon daji na fata. Haɗa magungunan yau da kullun na ipilimumab tare da sabon magani na nivolumab. Mace, 'yar shekara 49, ta sha kashi daya na maganin kuma a cikin makonni da yawa ƙwayarta ta ɓace gaba ɗaya, ta bar rami a cikin fata a ƙarƙashin ƙirjinta na hagu.